DE68928007D1 - Antigene Zusammensetzungen aus Fragmenten von Campylobacter pylori und Verfahren zu ihrer Herstellung und Verwendung - Google Patents

Antigene Zusammensetzungen aus Fragmenten von Campylobacter pylori und Verfahren zu ihrer Herstellung und Verwendung

Info

Publication number
DE68928007D1
DE68928007D1 DE68928007T DE68928007T DE68928007D1 DE 68928007 D1 DE68928007 D1 DE 68928007D1 DE 68928007 T DE68928007 T DE 68928007T DE 68928007 T DE68928007 T DE 68928007T DE 68928007 D1 DE68928007 D1 DE 68928007D1
Authority
DE
Germany
Prior art keywords
antigenic compositions
antigen
campylobacter pylori
occurrence
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68928007T
Other languages
English (en)
Other versions
DE68928007T2 (de
Inventor
Martin J Blaser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ENTERIC RES LAB Inc
Original Assignee
ENTERIC RES LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22566281&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68928007(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ENTERIC RES LAB Inc filed Critical ENTERIC RES LAB Inc
Publication of DE68928007D1 publication Critical patent/DE68928007D1/de
Application granted granted Critical
Publication of DE68928007T2 publication Critical patent/DE68928007T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE68928007T 1988-02-18 1989-02-17 Antigene Zusammensetzungen aus Fragmenten von Campylobacter pylori und Verfahren zu ihrer Herstellung und Verwendung Expired - Fee Related DE68928007T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/158,003 US5459041A (en) 1988-02-18 1988-02-18 Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection

Publications (2)

Publication Number Publication Date
DE68928007D1 true DE68928007D1 (de) 1997-06-05
DE68928007T2 DE68928007T2 (de) 1997-12-04

Family

ID=22566281

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68928007T Expired - Fee Related DE68928007T2 (de) 1988-02-18 1989-02-17 Antigene Zusammensetzungen aus Fragmenten von Campylobacter pylori und Verfahren zu ihrer Herstellung und Verwendung

Country Status (7)

Country Link
US (1) US5459041A (de)
EP (1) EP0329570B1 (de)
JP (1) JP2738947B2 (de)
AT (1) ATE152524T1 (de)
CA (1) CA1339067C (de)
DE (1) DE68928007T2 (de)
ES (1) ES2100850T3 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
USRE34101E (en) * 1991-03-19 1992-10-13 Baylor College Of Medicine Process for preparation of high molecular weight cell-associated protein of Campylobacter pylori and use for serological detection of Campylobacter pylori infection
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
US5262156A (en) * 1991-08-12 1993-11-16 Hycor Biomedical, Inc. Antigenic compositions and their use for the detection of Helicobacter pylori
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
JP3920320B2 (ja) * 1992-02-26 2007-05-30 ヴァンダービルト ユニバーシティ 精製されたＨｅｌｉｃｏｂａｃｔｅｒ ｐｙｌｏｒｉ由来の空胞形成毒素およびその使用方法
DE69333110T2 (de) 1992-03-02 2004-05-06 Chiron S.P.A. Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose
IT1262895B (it) * 1992-03-02 1996-07-22 Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
US7141244B1 (en) 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
US6130059A (en) * 1992-03-02 2000-10-10 Covacci; Antonello Helicobacter pylori proteins useful for vaccines and diagnostics
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
CA2067603A1 (en) * 1992-04-29 1993-10-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
GB9313437D0 (en) * 1993-06-30 1993-08-11 Smith Andrew W Pathogenicity sequences in helicobacter pylori
NZ314585A (en) * 1993-07-27 2000-08-25 Univ New South Wales Method of treating H. Pylori associated gastroduodenal disease
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
EP0719155A1 (de) * 1993-08-27 1996-07-03 Enteric Research Laboratories, Inc. ANTIGENE VON $i(CAMPYLOBACTER JEJUNI), UND VERFAHREN FÜR IHRE HERSTELLUNG UND VERWENDUNG
JP2512898Y2 (ja) * 1993-10-01 1996-10-02 厚一 植村 地下構造物用コンクリ―ト函体
US5780040A (en) * 1994-06-08 1998-07-14 Tufts University School Of Medicine Hospital, Inc. Helicobacter pylori nickel binding protein
GB2290866B (en) * 1994-06-29 1998-10-07 Reckitt & Colmann Prod Ltd Detection of Helicobacter pylori infection using antibodies to carbonic anhydrase
US5679564A (en) * 1994-10-05 1997-10-21 Antex Biologics, Inc. Methods for producing enhanced antigenic campylobacter bacteria and vaccines
CZ104297A3 (en) * 1994-10-05 1997-11-12 Microcarb Methods of producing higher antigenic heliobacter spp. and vaccines containing thereof
AU3814395A (en) * 1994-10-20 1996-05-15 Genelabs Diagnostics Pte Ltd Helicobacter pylori diagnostic methods and kits
GB9422991D0 (en) * 1994-11-15 1995-01-04 Cortecs Ltd Analytical method
GB9502899D0 (en) * 1995-02-15 1995-04-05 Cortecs Ltd Novel antigen
FR2736360B1 (fr) * 1995-07-04 1997-09-05 Pasteur Institut Clonage et caracterisation du gene fiba de h.pylori, production de souches aflagellees
ATE355375T1 (de) 1996-01-04 2006-03-15 Novartis Vaccines & Diagnostic Bakterioferritin aus helicobacter pylori
US5716791A (en) * 1996-05-09 1998-02-10 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5932430A (en) * 1996-05-09 1999-08-03 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5702911A (en) * 1996-08-15 1997-12-30 Chek-Med Systems, Inc. Diagnostic test composition
WO1998025141A2 (en) * 1996-12-05 1998-06-11 Idego Aps Immunochemical laminates and devices
SE9702242D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions V
FR2748477B1 (fr) * 1997-07-01 2001-07-13 Pasteur Merieux Serums Vacc Nouvelle proteine membranaire d'helicobacter pylori
FR2748478B1 (fr) * 1997-07-01 2001-07-13 Pasteur Merieux Serums Vacc Nouvelle proteine membranaire d'helicobacter pylori
JP3869556B2 (ja) * 1998-06-15 2007-01-17 勇 近藤 ヘリコバクター・ピロリ由来抗原及びそれを用いたヘリコバクター・ピロリ感染の診断方法
DE60012932T2 (de) 1999-06-23 2005-08-18 Cornell Research Foundation, Inc. Entwässerung/rehydratisierung von markierten liposomen auf einer prüfeinrichtung
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
TWI237695B (en) 1999-12-14 2005-08-11 Joy Biomedical Corp Helicobacter pylori antigens in blood
TWI222357B (en) * 2000-01-11 2004-10-21 Medical & Pharm Ind Tech & Dev Anti-ulcer pharmaceutical composition and the preparation and use thereof
DE10006432A1 (de) * 2000-02-14 2001-08-16 Ganzimmun Inst Fuer Ganzheitli Verfahren zum Nachweis von Helicobacter pylori in Stuhl- und Speichelproben
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
US20030166027A1 (en) * 2002-02-21 2003-09-04 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
ATE382861T1 (de) 2002-05-31 2008-01-15 Cornell Res Foundation Inc Universeller biosensor und verfahren zur verwendung
US7629127B2 (en) * 2005-01-21 2009-12-08 Dexall Biomedical Labs, Inc. Method for the visual detection of specific antibodies by the use of lateral flow assays
JP6795481B2 (ja) 2017-11-07 2020-12-02 日立金属株式会社 絶縁電線
JP6756692B2 (ja) 2017-11-07 2020-09-16 日立金属株式会社 絶縁電線

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422651D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
WO1987001119A1 (en) * 1985-08-16 1987-02-26 Gregory Murray Winn Monoclonal antibodies reactive against campylobacter pyloridis
US4882271A (en) * 1988-03-10 1989-11-21 Baylor College Of Medicine Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection
US5108892A (en) * 1989-08-03 1992-04-28 Promega Corporation Method of using a taq dna polymerase without 5'-3'-exonuclease activity

Also Published As

Publication number Publication date
US5459041A (en) 1995-10-17
ATE152524T1 (de) 1997-05-15
DE68928007T2 (de) 1997-12-04
ES2100850T3 (es) 1997-07-01
EP0329570B1 (de) 1997-05-02
EP0329570A3 (de) 1991-05-22
JP2738947B2 (ja) 1998-04-08
JPH0235096A (ja) 1990-02-05
EP0329570A2 (de) 1989-08-23
CA1339067C (en) 1997-07-29

Similar Documents

Publication Publication Date Title
DE68928007D1 (de) Antigene Zusammensetzungen aus Fragmenten von Campylobacter pylori und Verfahren zu ihrer Herstellung und Verwendung
DE3751432D1 (de) Rezeptoren für Immunkomplexe, Verfahren zur ihrer Herstellung und Verfahren zur Prüfung diese benutzend.
JPS6488155A (en) Immunological inspection for detecting antibody against antigen
ATE80735T1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
PL309211A1 (en) Heterogenous specific bond test used for detection or content determination of a given substance in a sample analysed, method of reducing non-specific bonding in pseudohomogenous tests and testing set for performing immunological test and those employing genetic probe
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
EP0351248A3 (en) Detection of an antibody and antigen in an immunoassay
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
Tanyuksel et al. Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
SE8900721D0 (sv) Methods for detection of antibodies to
Ren et al. A brief review of diagnosis of small ruminants brucellosis
ATE187251T1 (de) Verfahren zum nachweis der gegenwart einer mykobakterien-spezies und testsatz sowie antikörpes zur verwendung in diesem verfahren
KR870008186A (ko) 면역글로부린 Al(IgAl) 단면 분석에 의한 임질진단방법, 그 시약 및 키트(kit)
DE68922126T2 (de) Immunometrisches Verfahren zum Nachweis von Lipoprotein-Teilchen, anti-Lp(a) Monoklonale Antikörper und ihre Anwendung zur Diagnose von Atherosklerose.
EP0028133A3 (de) Verfahren zum Nachweis und zur Mengenbestimmung von Haptenen und Antigenen
Levine et al. Fast ELISA for measuring serum antibody responses
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
ATE106568T1 (de) Mittel für immunchemische tests enthaltend aminoxide.
ATE14799T1 (de) Verfahren zur feststellung sehr geringer antigen- und antikoerpermengen nach einem agglutinations- hemmungstest.
Cho Contemporary approaches to the serology of tuberculosis
DE69014087T2 (de) Verfahren zur quantitativen und qualitativen Bestimmung von Antikörpern gegen bakterielle Antigene mittels photometrischer Messung der Agglutination.
Fetterolf Antibody-Based Field Test Kits for Explosives
ES2004066A6 (es) Metodo para analisis cualitativo y-o cuantitativo de antigenos,anticuerpos yno microorganismos u otras celulas y su correspondiente equipo
ATE64466T1 (de) Immuntest.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee